Article Details

Dapagliflozin benefits older patients with heart failure undergoing valve replacement

Retrieved on: 2025-03-30 17:27:39

Tags for this article:

Click the tags to see associated articles and topics

Dapagliflozin benefits older patients with heart failure undergoing valve replacement. View article details on hiswai:

Summary

The article discusses dapagliflozin, an SGLT2 inhibitor, improving outcomes for older heart failure patients with diabetes undergoing aortic valve replacement surgery. Tags like 'cardiac surgery' and 'anti-diabetic drugs' relate to the study's cardiac and diabetic context.

Article found on: www.healio.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo